Your SlideShare is downloading. ×
Post myocardial infarction – pipeline review, h1 2012
Post myocardial infarction – pipeline review, h1 2012
Post myocardial infarction – pipeline review, h1 2012
Post myocardial infarction – pipeline review, h1 2012
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Post myocardial infarction – pipeline review, h1 2012


Published on || Post-Myocardial Infarction – Pipeline Review, H1 2012 || Market Research latest report || Post-Myocardial Infarction – Pipeline Review, H1 2012 || Market Research latest report

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. announces, The Latest market research report is available inits vast collection:Post-Myocardial Infarction – Pipeline Review, H1 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Post-Myocardial Infarction - Pipeline Review, H1 2012,provides an overview of the Post-Myocardial Infarction therapeutic pipeline. Thisreport provides information on the therapeutic development for Post-MyocardialInfarction, complete with latest updates, and special features on late-stage anddiscontinued projects. It also reviews key players involved in the therapeuticdevelopment for Post-Myocardial Infarction. Post-Myocardial Infarction - PipelineReview, H1 2012 is built using data and information sourced from Global MarketsDirect’s proprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Post-Myocardial Infarction.- A review of the Post-Myocardial Infarction products under development bycompanies and universities/research institutes based on information derived fromcompany and industry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combined
  • 2. therapeutics.Table of contents:List of Tables 3List of Figures 3Introduction 4Global Markets Direct Report Coverage 4Post-Myocardial Infarction Overview 5Therapeutics Development 6An Overview of Pipeline Products for Post-Myocardial Infarction 6Post-Myocardial Infarction Therapeutics under Development by Companies 8Post-Myocardial Infarction Therapeutics under Investigation byUniversities/Institutes 9Mid Clinical Stage Products 10Comparative Analysis 10Pre-Clinical Stage Products 11Comparative Analysis 11Post-Myocardial Infarction Therapeutics – Products under Development byCompanies 12Post-Myocardial Infarction Therapeutics – Products under Investigation byUniversities/Institutes 13Companies Involved in Post-Myocardial Infarction Therapeutics Development 14miRagen Therapeutics, Inc. 14Post-Myocardial Infarction – Therapeutics Assessment 15Assessment by Monotherapy Products 15Assessment by Molecule Type 16Drug Profiles 18Natrecor - Drug Profile 18Product Description 18Mechanism of Action 18R&D Progress 18MGN-1374 - Drug Profile 19Product Description 19Mechanism of Action 19R&D Progress 19
  • 3. Post-Myocardial Infarction Therapeutics – Drug Profile Updates 20Post-Myocardial Infarction – Product Development Milestones 21List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H1 2012 Review, H12012&PubId=&pagenum=1Refractory Angina – Pipeline Review, H1 2012Post-Myocardial Infarction – Pipeline Review, H1 2012Proteinuria – Pipeline Review, H1 2012Ocular Pain – Pipeline Review, H1 2012Pediculosis (Head Lice Infestation) – Pipeline Review, H1 2012Allergic Rhino-Conjunctivitis – Pipeline Review, H1 2012Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H1 2012Thyroid Gland Disorders – Pipeline Review, H1 2012
  • 4. Tinea Corporis – Pipeline Review, H1 2012Pulmonary Fibrosis – Pipeline Review, H1 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: